CIK 0001833769
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Hyperfine, Inc.
Sign in to watch- Ticker
- HYPR
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 866-796-6767
- Business address
- 351 NEW WHITFIELD STREET, GUILFORD, CT, 06437
- Former names
- HealthCor Catalio Acquisition Corp.
- 4 Open-market sale Gen Counsel & Corp Secretary sold 1,891 shares at $1.45 ($2,742)
- 4 Open-market buy Director bought 64,213 shares at $1.48 ($95,164)
- 4 Open-market buy Director bought 303,137 shares at $1.46 ($441,671)
- 4 Open-market sale CMO and Chief Strategy Officer sold 4,846 shares at $2.02 ($9,789)
- 4 Open-market sale Gen Counsel & Corp Secretary sold 10,542 shares at $2.02 ($21,295)
- 4 Open-market buy Director bought 52,848 shares at $2.26 ($119,436)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award President and CEO acquired 649,350 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Commercial Officer acquired 96,875 shares (grant or award)
- 4 Grant or award Gen Counsel & Corp Secretary acquired 127,500 shares (grant or award)
- 4 Grant or award CMO and Chief Strategy Officer acquired 92,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 150,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 127,167 shares (grant or award)
- 4 Derivatives Options or other derivatives
Page 5 of 8 · 144 filings